v3.25.2
Document and Entity Information - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Aug. 22, 2025
Jun. 30, 2025
Document Information        
Document Type 10-K/A      
Document Annual Report true      
Document Period End Date Dec. 31, 2024      
Document Transition Report false      
Securities Act File Number 001-41015      
Entity Registrant Name VSee Health, Inc.      
Entity Incorporation, State or Country Code DE      
Entity Tax Identification Number 86-2970927      
Entity Address, Address Line One 980 N Federal Hwy      
Entity Address, Address Line Two Suite 304      
Entity Address, City or Town Boca Raton      
Entity Address, State or Province FL      
Entity Address, Postal Zip Code 33432      
City Area Code 516      
Local Phone Number 672-7068      
Entity Well-known Seasoned Issuer No      
Entity Voluntary Filers No      
Entity Current Reporting Status No      
Entity Interactive Data Current Yes      
Entity Filer Category Non-accelerated Filer      
Entity Small Business true      
Entity Emerging Growth Company true      
Entity Ex Transition Period false      
ICFR Auditor Attestation Flag false      
Document Financial Statement Error Correction [Flag] true      
Document Financial Statement Restatement Recovery Analysis [Flag] false      
Entity Shell Company false      
Entity Public Float       $ 18,170
Entity Common Stock, Shares Outstanding     16,422,690  
Entity Central Index Key 0001864531      
Current Fiscal Year End Date --12-31      
Document Fiscal Year Focus 2024      
Document Fiscal Period Focus FY      
Amendment Flag true      
Amendment Description This Amendment No. 1 to our Annual Report on Form 10-K for the years ended December 31, 2024 and 2023 (the “Form 10-K”), originally filed with the Securities and Exchange Commission on August 28, 2025, is being filed to (i) update the date on the consent, (ii) correct the address referenced in Exhibit 23.2, (iii) correct certain hyperlink references in the Form 10-K, and (iv) include a comprehensive restatement of previously filed periods. This Comprehensive Form 10-K contains our audited financial statements for the fiscal year ended December 31, 2024, as well as restated financial statements for the fiscal year ended December 31, 2023 and the unaudited consolidated financial statements for the quarterly reporting periods ended March 31, 2023, June 30, 2023, and September 30, 2023, and March 31, 2024, June 30, 2024, and September 30, 2024. The Company also identified certain errors in the recognition and measurement of transactions as of the business combination date (June 24, 2024). Except as described above, no other changes have been made to the Form 10-K. This Amendment does not reflect events occurring after the filing of the Form 10-K and does not modify or update any other disclosures made in the Form 10-K.      
Auditor Name WithumSmith+Brown, PC Astra Audit & Advisory LLC    
Auditor Location San Francisco, California Tampa, Florida    
Auditor Firm ID 100 6920    
Common Stock        
Document Information        
Title of 12(b) Security Common Stock, par value $0.0001 per share      
Trading Symbol VSEE      
Security Exchange Name NASDAQ      
Warrants        
Document Information        
Title of 12(b) Security Warrants, which entitles the holder to purchase one(1) share of common stock at a price of $11.50 per whole share      
Trading Symbol VSEEW      
Security Exchange Name NASDAQ